Correction to: Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signaling.

Yang, Na; Zou, Chunpeng; Luo, Wu; Xu, Diyun; Wang, Mengyang; Wang, Yi; Wu, Gaojun; Shan, Peiren; Liang, Guang

Yang, Na; Zou, Chunpeng; Luo, Wu; Xu, Diyun; Wang, Mengyang; Wang, Yi; Wu, Gaojun; Shan, Peiren; Liang, Guang.

Afiliação

Yang N; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Zou C; Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Luo W; Department of Ultrasonography, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xu D; Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wang M; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Wang Y; Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wu G; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Shan P; Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, Yanbian University, Yanji, China.
Liang G; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.

Phytother Res ; 38(3): 1715-1716, 2024 Mar.

Article em En | MEDLINE | ID: mdl-38317321

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Phytother Res Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google